leisure time -WSS

leisure time

author：hotspot 2025-10-02 19:38:27 - browse：6

Cambridge: Biogen — Ruby Wallau for STAT

Biogen, the iconic but embattled biotech firm, is shuttering Biogen Digital Health, its roughly 150-person group focused on using new types of data like those from mobile phones and smart watches, and ending a clinical trial being conducted with Apple early, STAT has learned.

Biogen confirmed the organizational change, but said it might lean even more on digital tech startups in the future.

“It’s certainly not an abandonment of digital, it’s more of a realignment of resources and priorities,” said Adam Keeney, Biogen’s executive vice president and head of corporate development. However, he later acknowledged, Biogen Digital Health, a separate entity, “would no longer continue in its current form.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Is there an 'orca uprising'? Like orcas themselves, the answer is complex.

explore

WSS

'Patient friction coefficient' can gauge a clinical trial's patient burden

Texas board proposes rules on abortion law emergency exemption

'Patient friction coefficient' can gauge a clinical trial's patient burden

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

Adam's Take: Intra

Yancopoulos of Regeneron works to expand Dupixent success

hotspot

leisure time

leisure time

23andMe had bad news about my health. I wish a person had delivered it

Women's World Cup brings attention to abuse in soccer

Medicare details structure of new drug price negotiation program

Superbugs, antibiotic resistance get scrutiny in congress

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

Jerome Adams on the need for new antivirals for Covid

Watch the official trailer for 'Ahsoka' series

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Grail's uphill battle for Medicare to cover its cancer screening test

knowledge

Cuban government calls US nuclear submarine stop a 'provocative escalation'

Antibody drugs appear effective. Now can we make enough of them?

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

Steward Health Care expansion into Malta flopped

Superbugs, antibiotic resistance get scrutiny in congress

Blinken talks high

leisure time

explore

hotspot

hotspot